Sanjay Singh

Sanjay Singh has extensive experience in the pharmaceutical industry, working in various roles for multiple companies. Sanjay is currently the Director and Clinical Project Lead at Genmab since January 2022. Prior to that, they held several positions at Bristol-Myers Squibb, including Associate Director for Global Clinical Operations and Global Clinical Trial Management from 2014 to 2022. Sanjay also served as a Global Senior Clinical Trial Manager from 2014 to 2018. Before joining Bristol-Myers Squibb, Sanjay worked as a Clinical Operations Consultant at AstraZeneca for a brief period in 2014. Sanjay was also a Global Study Manager at Daiichi Sankyo from 2011 to 2013 and a Clinical Trial Leader at Eli Lilly and Company from 2008 to 2011.

Sanjay Singh pursued their Bachelor of Science degree in Pharmacy from the College of Pharmaceutical Sciences at Berhampur University in India. Sanjay completed this program from 1996 to 2000. Later, from 2000 to 2002, Sanjay attended the Institute of Technology & Science to obtain their MBA degree, specializing in Marketing and International Business.